Prevalence of high‐risk human papillomavirus infection in women with ovarian endometriosis M Heidarpour, M Derakhshan, M Derakhshan‐Horeh, M Kheirollahi, ... Journal of Obstetrics and Gynaecology Research 43 (1), 135-139, 2017 | 54 | 2017 |
The HOTTIP (HOXA transcript at the distal tip) lncRNA: Review of oncogenic roles in human S Ghafouri-Fard, S Dashti, M Taheri Biomedicine & Pharmacotherapy 127, 110158, 2020 | 51 | 2020 |
Brain tumors: Special characters for research and banking M Kheirollahi, S Dashti, Z Khalaj, F Nazemroaia, P Mahzouni Advanced biomedical research 4 (1), 4, 2015 | 44 | 2015 |
TINCR: An lncRNA with dual functions in the carcinogenesis process S Ghafouri-Fard, S Dashti, M Taheri, MD Omrani Non-coding RNA Research 5 (3), 109-115, 2020 | 38 | 2020 |
Expression analysis of vimentin and the related lncRNA network in breast cancer M Mohebi, S Ghafouri-Fard, MH Modarressi, S Dashti, A Zekri, ... Experimental and molecular pathology 115, 104439, 2020 | 29 | 2020 |
In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples S Dashti, Z Taherian-Esfahani, V Kholghi-Oskooei, R Noroozi, ... Scientific reports 10 (1), 8316, 2020 | 29 | 2020 |
A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies S Ghafouri-Fard, S Dashti, M Farsi, BM Hussen, M Taheri Biomedicine & Pharmacotherapy 137, 111366, 2021 | 27 | 2021 |
An in-silico method leads to recognition of hub genes and crucial pathways in survival of patients with breast cancer S Dashti, M Taheri, S Ghafouri-Fard Scientific reports 10 (1), 18770, 2020 | 23 | 2020 |
Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response S Ghafouri‐Fard, H Shoorei, S Dashti, W Branicki, M Taheri Journal of Cellular Physiology 235 (12), 9269-9290, 2020 | 20 | 2020 |
The role of long non-coding RNA CASC2 in the carcinogenesis process S Ghafouri-Fard, S Dashti, M Taheri Biomedicine & Pharmacotherapy 127, 110202, 2020 | 20 | 2020 |
Assessment of the expression pattern of mTOR‐associated lncRNAs and their genomic variants in the patients with breast cancer Z Taherian‐Esfahani, M Taheri, S Dashti, V Kholghi‐Oskooei, ... Journal of Cellular Physiology 234 (12), 22044-22056, 2019 | 19 | 2019 |
Mutation analysis of SLC3A1 and SLC7A9 genes in patients with cystinuria L Koulivand, M Mohammadi, B Ezatpour, R Salehi, S Markazi, S Dashti, ... Urolithiasis 43, 447-453, 2015 | 19 | 2015 |
PCAT1: An oncogenic lncRNA in diverse cancers and a putative therapeutic target S Ghafouri-Fard, S Dashti, M Taheri Experimental and Molecular Pathology 114, 104429, 2020 | 15 | 2020 |
Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies S Dashti, Z Taherian-Esfahani, A Keshtkar, S Ghafouri-Fard BMC medical genetics 20, 1-17, 2019 | 15 | 2019 |
X-inactive-specific transcript: review of its functions in the carcinogenesis S Ghafouri-Fard, S Dashti, M Farsi, M Taheri, SA Mousavinejad Frontiers in cell and developmental biology 9, 690522, 2021 | 14 | 2021 |
BCYRN1: an oncogenic lncRNA in diverse cancers S Ghafouri-Fard, S Dashti, BM Hussen, M Farsi, M Taheri Pathology-Research and Practice 220, 153385, 2021 | 14 | 2021 |
HOX transcript antisense RNA: an oncogenic lncRNA in diverse malignancies S Ghafouri-Fard, S Dashti, M Farsi, M Taheri Experimental and Molecular Pathology 118, 104578, 2021 | 14 | 2021 |
Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer S Ghafouri-Fard, Z Taherian-Esfahani, S Dashti, VK Oskooei, M Taheri, ... Experimental and Molecular Pathology 114, 104415, 2020 | 14 | 2020 |
Deleted in lymphocytic leukemia 2 (DLEU2): An lncRNA with dissimilar roles in different cancers S Ghafouri-Fard, S Dashti, M Farsi, M Taheri Biomedicine & Pharmacotherapy 133, 111093, 2021 | 12 | 2021 |
Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer S Dashti, S Ghafouri-Fard, F Esfandi, VK Oskooei, S Arsang-Jang, ... Experimental and molecular pathology 112, 104359, 2020 | 9 | 2020 |